These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28691737)

  • 1. Evaluating the antifibrotic potency of galunisertib in a human ex vivo model of liver fibrosis.
    Luangmonkong T; Suriguga S; Bigaeva E; Boersema M; Oosterhuis D; de Jong KP; Schuppan D; Mutsaers HAM; Olinga P
    Br J Pharmacol; 2017 Sep; 174(18):3107-3117. PubMed ID: 28691737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galunisertib modifies the liver fibrotic composition in the Abcb4Ko mouse model.
    Hammad S; Cavalcanti E; Werle J; Caruso ML; Dropmann A; Ignazzi A; Ebert MP; Dooley S; Giannelli G
    Arch Toxicol; 2018 Jul; 92(7):2297-2309. PubMed ID: 29808285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring organ-specific features of fibrogenesis using murine precision-cut tissue slices.
    Bigaeva E; Gore E; Mutsaers HAM; Oosterhuis D; Kim YO; Schuppan D; Bank RA; Boersema M; Olinga P
    Biochim Biophys Acta Mol Basis Dis; 2020 Jan; 1866(1):165582. PubMed ID: 31676376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGFβR1 Blockade with Galunisertib (LY2157299) Enhances Anti-Neuroblastoma Activity of the Anti-GD2 Antibody Dinutuximab (ch14.18) with Natural Killer Cells.
    Tran HC; Wan Z; Sheard MA; Sun J; Jackson JR; Malvar J; Xu Y; Wang L; Sposto R; Kim ES; Asgharzadeh S; Seeger RC
    Clin Cancer Res; 2017 Feb; 23(3):804-813. PubMed ID: 27756784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promotion of liver regeneration and anti‑fibrotic effects of the TGF‑β receptor kinase inhibitor galunisertib in CCl4‑treated mice.
    Masuda A; Nakamura T; Abe M; Iwamoto H; Sakaue T; Tanaka T; Suzuki H; Koga H; Torimura T
    Int J Mol Med; 2020 Jul; 46(1):427-438. PubMed ID: 32377696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted delivery of galunisertib using machine perfusion reduces fibrogenesis in an integrated ex vivo renal transplant and fibrogenesis model.
    van Leeuwen LL; Ruigrok MJR; Kessler BM; Leuvenink HGD; Olinga P
    Br J Pharmacol; 2024 Feb; 181(3):464-479. PubMed ID: 37596999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of TGF-beta signalling inhibition with galunisertib (LY2157299) in hepatocellular carcinoma models and in ex vivo whole tumor tissue samples from patients.
    Serova M; Tijeras-Raballand A; Dos Santos C; Albuquerque M; Paradis V; Neuzillet C; Benhadji KA; Raymond E; Faivre S; de Gramont A
    Oncotarget; 2015 Aug; 6(25):21614-27. PubMed ID: 26057634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cirrhotic Human Liver Extracellular Matrix 3D Scaffolds Promote Smad-Dependent TGF-β1 Epithelial Mesenchymal Transition.
    Mazza G; Telese A; Al-Akkad W; Frenguelli L; Levi A; Marrali M; Longato L; Thanapirom K; Vilia MG; Lombardi B; Crowley C; Crawford M; Karsdal MA; Leeming DJ; Marrone G; Bottcher K; Robinson B; Del Rio Hernandez A; Tamburrino D; Spoletini G; Malago M; Hall AR; Godovac-Zimmermann J; Luong TV; De Coppi P; Pinzani M; Rombouts K
    Cells; 2019 Dec; 9(1):. PubMed ID: 31905709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galunisertib Exerts Antifibrotic Effects on TGF-β-Induced Fibroproliferative Dermal Fibroblasts.
    Peterson JM; Jay JW; Wang Y; Joglar AA; Prasai A; Palackic A; Wolf SE; El Ayadi A
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and ex vivo anti-fibrotic effects of LY2109761, a small molecule inhibitor against TGF-β.
    Luangmonkong T; Suriguga S; Adhyatmika A; Adlia A; Oosterhuis D; Suthisisang C; de Jong KP; Mutsaers HAM; Olinga P
    Toxicol Appl Pharmacol; 2018 Sep; 355():127-137. PubMed ID: 30008374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galunisertib suppresses the staminal phenotype in hepatocellular carcinoma by modulating CD44 expression.
    Rani B; Malfettone A; Dituri F; Soukupova J; Lupo L; Mancarella S; Fabregat I; Giannelli G
    Cell Death Dis; 2018 Mar; 9(3):373. PubMed ID: 29515105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galunisertib attenuates progression of trauma-induced heterotopic ossification via blockage of Smad2/3 signaling in mice.
    Mao D; Mi J; Pan X; Zhao G; Rui Y
    Eur J Pharmacol; 2022 Aug; 928():175109. PubMed ID: 35738451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvianolic acid B exerts anti-liver fibrosis effects via inhibition of MAPK-mediated phospho-Smad2/3 at linker regions in vivo and in vitro.
    Wu C; Chen W; Ding H; Li D; Wen G; Zhang C; Lu W; Chen M; Yang Y
    Life Sci; 2019 Dec; 239():116881. PubMed ID: 31678285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tumor activity of the TGF-β receptor kinase inhibitor galunisertib (LY2157299 monohydrate) in patient-derived tumor xenografts.
    Maier A; Peille AL; Vuaroqueaux V; Lahn M
    Cell Oncol (Dordr); 2015 Apr; 38(2):131-44. PubMed ID: 25573078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PI3K inhibition reduces murine and human liver fibrogenesis in precision-cut liver slices.
    Gore E; Bigaeva E; Oldenburger A; Kim YO; Rippmann JF; Schuppan D; Boersema M; Olinga P
    Biochem Pharmacol; 2019 Nov; 169():113633. PubMed ID: 31494146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compound Astragalus and Salvia miltiorrhiza Extract exerts anti-fibrosis by mediating TGF-beta/Smad signaling in myofibroblasts.
    Yang Y; Yang S; Chen M; Zhang X; Zou Y; Zhang X
    J Ethnopharmacol; 2008 Jul; 118(2):264-70. PubMed ID: 18502066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precision-cut liver slices as a model for the early onset of liver fibrosis to test antifibrotic drugs.
    Westra IM; Oosterhuis D; Groothuis GM; Olinga P
    Toxicol Appl Pharmacol; 2014 Jan; 274(2):328-38. PubMed ID: 24321339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NGS-based transcriptome profiling reveals biomarkers for companion diagnostics of the TGF-β receptor blocker galunisertib in HCC.
    Cao Y; Agarwal R; Dituri F; Lupo L; Trerotoli P; Mancarella S; Winter P; Giannelli G
    Cell Death Dis; 2017 Feb; 8(2):e2634. PubMed ID: 28230858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of a precision-cut rat liver slice model for the evaluation of antifibrotic compounds.
    Huang X; Cai H; Ammar R; Zhang Y; Wang Y; Ravi K; Thompson J; Jarai G
    Am J Physiol Gastrointest Liver Physiol; 2019 Jan; 316(1):G15-G24. PubMed ID: 30406699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galunisertib (LY2157299), a transforming growth factor-β receptor I kinase inhibitor, attenuates acute pancreatitis in rats.
    Liu X; Yu M; Chen Y; Zhang J
    Braz J Med Biol Res; 2016 Aug; 49(9):e5388. PubMed ID: 27509307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.